Jiali Zhang

Jiali Zhang is a Postgraduate Associate in the Department of Pathology at the Yale School of Medicine. Her research focuses on cancer genomics, tumor suppressor pathways, and molecular mechanisms of HPV-associated cancers. She has contributed to advancements in cell-based immunotherapies, CRISPR-based functional genomics, and translational diagnostics.

Her work integrates genomic analysis with clinical applications, particularly in lung cancer, head and neck cancers, and colorectal cancer. Key projects include investigating TRAF3's tumor suppressor role, epigenetic modifications in lung cancer, and single-cell sequencing for precision medicine. She has developed novel assays for studying tumor-immune interactions and cancer cell cytotoxicity.

Publications span topics such as alternative NF-κB signaling in HPV+ cancers, biomarker discovery for colorectal cancer, and combination therapies overcoming drug resistance in head and neck tumors. Her research bridges basic science and clinical practice, emphasizing diagnostic innovation and therapeutic target identification.

Though no specific awards or grants are listed in the provided text, her extensive publication record reflects sustained contributions to cancer biology and translational oncology.